A Study to Assess Usability of Risankizumab Autoinjector Combination Product in Participants With Moderate to Severe Plaque Psoriasis
Clinical trial NCT03875508 · COMPLETED
Trial details
- NCT number
- NCT03875508
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-04
- Primary completion
- 2020-04-24
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.